These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37126928)

  • 21. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
    Balamuth NJ; Nichols KE; Paessler M; Teachey DT
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus.
    Zhong L; Krummenacher C; Zhang W; Hong J; Feng Q; Zhao Q; Chen Y; Zeng MS; Zeng YX; Xu M; Zhang X
    Virol J; 2022 Nov; 19(1):196. PubMed ID: 36424667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection.
    Okano M; Gross TG
    Am J Med Sci; 2012 Jun; 343(6):483-9. PubMed ID: 22104426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
    Liu JH; Liu W; Li YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.
    Fox CP; Shannon-Lowe C; Gothard P; Kishore B; Neilson J; O'Connor N; Rowe M
    Clin Infect Dis; 2010 Jul; 51(1):66-9. PubMed ID: 20504238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses.
    Kong XW; Zhang X; Bu GL; Xu HQ; Kang YF; Sun C; Zhu QY; Ma RB; Liu Z; Zeng YX; Zeng MS; Hu ZL
    J Virol; 2022 May; 96(9):e0033622. PubMed ID: 35404082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.
    Hayashi K; Ohara N; Teramoto N; Onoda S; Chen HL; Oka T; Kondo E; Yoshino T; Takahashi K; Yates J; Akagi T
    Am J Pathol; 2001 Apr; 158(4):1533-42. PubMed ID: 11290571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cord Blood Transplantation Following Reduced-Intensity Conditioning for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis during Systemic Lupus Erythematosus Treatment.
    Kuriyama T; Kawano N; Yamashita K; Kikuchi I
    J Clin Exp Hematop; 2016; 56(2):126-129. PubMed ID: 27980302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Yin Q; Wang J; Wang Z
    Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH).
    Imashuku S; Tabata Y; Teramura T; Hibi S
    Leuk Lymphoma; 2000 Sep; 39(1-2):37-49. PubMed ID: 10975382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
    Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
    BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County.
    Kelesidis T; Humphries R; Terashita D; Eshaghian S; Territo MC; Said J; Lewinski M; Currier JS; Pegues D
    J Med Virol; 2012 May; 84(5):777-85. PubMed ID: 22431026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350.
    Cui X; Cao Z; Chen Q; Arjunaraja S; Snow AL; Snapper CM
    Vaccine; 2016 Jul; 34(34):4050-5. PubMed ID: 27291087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.
    Khyatti M; Patel PC; Stefanescu I; Menezes J
    J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms and haplotypes of IL2RA, IL10, IFNG, IRF5, and CCR2 are associated with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Tang N; Huang J; Chen C; Wu X; Xu H; Chen G; Xue H
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29097. PubMed ID: 34031980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.
    Xu L; Guo X; Guan H
    Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.
    You Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Jan; 101(2):e28542. PubMed ID: 35029211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.